- Home
- ADN vs QNTM Comparison
ADN vs QNTM Comparison
Compare ADN & QNTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADN
- QNTM
- Stock Information
- Founded
- ADN 2006
- QNTM 1998
- Country
- ADN United States
- QNTM Canada
- Employees
- ADN N/A
- QNTM N/A
- Industry
- ADN Power Generation
- QNTM
- Sector
- ADN Utilities
- QNTM
- Exchange
- ADN Nasdaq
- QNTM NYSE
- Market Cap
- ADN 8.5M
- QNTM 9.1M
- IPO Year
- ADN N/A
- QNTM N/A
- Fundamental
- Price
- ADN $5.00
- QNTM $3.48
- Analyst Decision
- ADN
- QNTM
- Analyst Count
- ADN 0
- QNTM 0
- Target Price
- ADN N/A
- QNTM N/A
- AVG Volume (30 Days)
- ADN 62.8K
- QNTM 97.9K
- Earning Date
- ADN 10-15-2024
- QNTM 12-31-2024
- Dividend Yield
- ADN N/A
- QNTM N/A
- EPS Growth
- ADN N/A
- QNTM N/A
- EPS
- ADN N/A
- QNTM N/A
- Revenue
- ADN $7,026,000.00
- QNTM N/A
- Revenue This Year
- ADN $2,232.99
- QNTM N/A
- Revenue Next Year
- ADN $91.56
- QNTM N/A
- P/E Ratio
- ADN N/A
- QNTM N/A
- Revenue Growth
- ADN 9.01
- QNTM N/A
- 52 Week Low
- ADN $1.71
- QNTM $3.42
- 52 Week High
- ADN $10.11
- QNTM $70.85
- Technical
- Relative Strength Index (RSI)
- ADN 45.74
- QNTM 30.23
- Support Level
- ADN $5.79
- QNTM $4.03
- Resistance Level
- ADN $6.77
- QNTM $4.50
- Average True Range (ATR)
- ADN 0.64
- QNTM 0.55
- MACD
- ADN -0.17
- QNTM -0.06
- Stochastic Oscillator
- ADN 34.44
- QNTM 2.63
About ADN Advent Technologies Holdings Inc.
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.
About QNTM QUANTUM BIOPHARMA LTD
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.